• 21 September 2018

    Medtronic to buy Mazor Robotics under $1.64bn deal

    Medtronic has signed a definitive merger agreement to acquire 100% of the outstanding ordinary shares of surgical systems developer Mazor Robotics for a total consideration of about $1.64bn.

  • 20 September 2018

    Cancer Genetics and NovellusDx agree to merge

    US-based oncology diagnostic products company Cancer Genetics has entered into a definitive agreement to merge with Israeli functional genomics firm NovellusDx.